Mandal Kaushik, Ashorobi Damilola, Lee Alice, Liao Huijuan, Kumar Salini C, Rosenthal David S
Division of Endocrinology, Nassau University Medical Center, 2201 Hempstead Turnpike, East Meadow, NY 11554, USA.
Case Rep Endocrinol. 2021 Aug 30;2021:8479193. doi: 10.1155/2021/8479193. eCollection 2021.
Sporadic reports of factitious elevations of thyroid hormones related to laboratory interference from autoantibodies and multiple myeloma paraproteins have appeared in the literature. Such clinically confusing laboratory results can lead to erroneous diagnoses and inappropriate treatments. We report an additional case of a patient with multiple myeloma and an IgG paraproteinemia who had such a spurious elevation of total T3 complicating her levothyroxine management of hypothyroidism. In addition, we alert clinicians that differences in performance characteristics between various manufacturers' test platforms may also cause spurious reports.
文献中曾有散在报道称,自身抗体和多发性骨髓瘤副蛋白导致的实验室干扰会致使甲状腺激素出现人为升高。这类在临床上容易造成混淆的实验室结果可能会导致错误诊断和不恰当的治疗。我们报告了另外一例患有多发性骨髓瘤和IgG副蛋白血症的患者,其总T3出现这种假性升高,使其甲状腺功能减退的左甲状腺素治疗变得复杂。此外,我们提醒临床医生,不同厂家检测平台的性能特征差异也可能导致假性报告。